{"Abstract": [0], "Chimeric": [1], "antigen": [2, 62], "receptor": [3], "(CAR)-T": [4], "cell": [5, 30, 53, 84, 133, 153], "therapy": [6, 54, 154], "is": [7, 90], "a": [8, 87], "revolutionary": [9], "new": [10], "pillar": [11], "in": [12, 43, 131, 139, 155], "cancer": [13], "treatment.": [14], "Although": [15], "treatment": [16], "with": [17, 25, 78, 115], "CAR-T": [18, 41, 52, 79, 83, 113, 132, 152], "cells": [19, 42, 80, 114], "has": [20], "produced": [21], "remarkable": [22], "clinical": [23, 137], "responses": [24], "certain": [26], "subsets": [27], "of": [28, 40, 151], "B": [29], "leukemia": [31], "or": [32], "lymphoma,": [33], "many": [34], "challenges": [35], "limit": [36], "the": [37, 72], "therapeutic": [38], "efficacy": [39, 138], "solid": [44, 144, 160], "tumors": [45, 145], "and": [46, 66, 74, 94, 107, 119, 143, 146, 159], "hematological": [47, 141, 157], "malignancies.": [48], "Barriers": [49], "to": [50, 92, 100, 109, 135, 148], "effective": [51], "include": [55], "severe": [56], "life-threatening": [57], "toxicities,": [58], "modest": [59], "anti-tumor": [60, 117], "activity,": [61], "escape,": [63], "restricted": [64], "trafficking,": [65], "limited": [67], "tumor": [68, 75], "infiltration.": [69], "In": [70, 98, 124], "addition,": [71], "host": [73], "microenvironment": [76], "interactions": [77], "critically": [81], "alter": [82], "function.": [85], "Furthermore,": [86], "complex": [88], "workforce": [89], "required": [91], "develop": [93], "implement": [95], "these": [96, 102], "treatments.": [97], "order": [99], "overcome": [101, 149], "significant": [103], "challenges,": [104], "innovative": [105], "strategies": [106, 147], "approaches": [108], "engineer": [110], "more": [111], "powerful": [112], "improved": [116], "activity": [118], "decreased": [120], "toxicity": [121], "are": [122], "necessary.": [123], "this": [125], "review,": [126], "we": [127], "discuss": [128], "recent": [129], "innovations": [130], "engineering": [134], "improve": [136], "both": [140, 156], "malignancy": [142, 158], "limitations": [150], "tumors.": [161]}